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 وابئيات أنواع السرطاانت املختلفة اليت مت اإلبالغ عنها يف
البصرة، العراق
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abstract: Objectives: This study aimed to report the incidence and pattern of various types of cancers and their 
distribution across various demographic groups in Basra, Iraq. Methods: Cancer cases recorded during 2017 at 
the Basra Cancer Control Centre, the Department of Pathology and Forensic Medicine, the Basra Oncology and 
Hematology Centre, the Basra Children’s Hospital and at private laboratories were included in the study. Patients’ 
records were analysed for information related to age, gender, residence and type of cancer. Incidences for different 
geographical regions and distribution of incidences across age groups were recorded as percentages. The mean 
age was recorded for patients of different genders and age groups. Incidence rates per 100,000 were calculated 
for different types of cancer. Results: A total of 2,163 cancer cases were identified of which 2,020 were in adults 
(93.4%) and 143 were in children (6.6%). Among adults, most cancers were found in females (59%). Patients’ mean 
age at diagnosis was 51.4 ± 19.6 years for adults and 6.4 ± 4.23 years for children. Cancer incidence rates per 
100,000 people increased with age. Breast cancer was the most frequent cancer type found in adult females, with 
an incidence rate of 60.64 per 100,000 people. The most common types of cancer found in adult males were urinary 
bladder and lung and bronchus cancers; leukaemia was the most common cancer in children. Conclusion: The 
findings from this study can be used for predicting cancer epidemiology in Basra, Iraq, and to identify subsets of the 
population at high risk of cancer incidence. This information will help healthcare providers to adequately respond 
to the demands of diagnosis, treatment and palliative care for such patients.
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امللخ�ص: الهدف: هدفت هذه الدرا�سة اإىل الإبالغ عن وقوع واأمناط الأنواع املختلفة من ال�رسطانات وتوزيعها عرب املجموعات الدميوغرافية 
ال�رسطان يف  2017 يف مركز مكافحة  امل�سجلة خالل عام  ال�رسطان  الدرا�سة على حالت  �سملت  الطريقة:  العراق.  الب�رسة،  املختلفة يف 
الب�رسة لالأطفال، واملختربات اخلا�سة.  الدم بالب�رسة، وم�ست�سفى  واأمرا�ض  الأورام  ال�رسعي، ومركز  الباثولوجيا والطب  الب�رسة، وق�سم 
مت حتليل �سجالت املر�سى للح�سول على معلومات تتعلق بالعمر واجلن�ض والإقامة ونوع ال�رسطان. مت ت�سجيل حالت الوقوع ملختلف 
املناطق اجلغرافية وتوزيع ووقوعها عرب الفئات العمرية كن�سب مئوية. مت ت�سجيل متو�سط العمر للمر�سى من خمتلف الأجنا�ض والفئات 
العمرية. مت ح�ساب معدلت الوقوع لكل 100,000 ملختلف اأنواع ال�رسطانات. النتائج: مت حتديد ما جمموعه 2,163 حالة �رسطان، 2020 
منها يف البالغني )%93.4( و 143 يف الأطفال )%6.6(. من بني البالغني، مت العثور على معظم ال�رسطانات يف الإناث )%95(. كان متو�سط 
عمر املر�سى عند الت�سخي�ض 19.6 ± 51.4 �سنة للبالغني و 32.4 ± 6.4 �سنة لالأطفال. زادت معدلت وقوع ال�رسطان لكل 100,000 �سخ�ض 
 100,000 لكل   60.64 الوقوع  بلغ معدل  البالغات، حيث  الإناث  �سيوًعا بني  ال�رسطانات  اأنواع  اأكرث  الثدي  العمر. كان �رسطان  تقدم  مع 
�سخ�ض. اأكرث اأنواع ال�رسطانات �سيوًعا لدى الذكور البالغني هي �رسطان املثانة البولية والرئة والق�سبات الهوائية. كان �رسطان الدم اأكرث 
اأنواع ال�رسطانات �سيوًعا عند الأطفال. اخلال�صة: ميكن ا�ستخدام نتائج هذه الدرا�سة للتنبوؤ بوبائيات ال�رسطان يف الب�رسة، العراق، ولتحديد 
املجموعات الفرعية من ال�سكان املعر�سني خلطر الإ�سابة بال�رسطان. �ست�ساعد هذه املعلومات مقدمي الرعاية ال�سحية على ال�ستجابة 
ب�سكل منا�سب ملتطلبات الت�سخي�ض والعالج والرعاية امللطفة لهوؤلء املر�سى.
الكلمات املفتاحية: الأورام؛ وقوع؛ الوبائيات؛ الدميوغرافيا؛ العراق.
Epidemiology of Different Types of Cancers 
Reported in Basra, Iraq
*Rafid A. Abood,1,2 Kareem A. Abdahmed,3 Seena S. Mazyed3
Sultan Qaboos University Med J, August 2020, Vol. 20, Iss. 3, pp. e295–300, Epub. 5 Oct 20
Submitted 3 Nov 19
Revision Req. 16 Jan 20; Revisions Recd. 26 Feb 20
Accepted 25 Mar 20 https://doi.org/10.18295/squmj.2020.20.03.008
clinical & basic research
Advances in Knowledge
- This epidemiological study provides the incidence of various types of cancer in adult (males and females) and in children in the Basra 
Governorate of Iraq.
- The most frequent cancer types in males in Basra, Iraq are cancer of bladder, cancer of lung and bronchus, and lymphoma.
- The most frequent cancer types in females in Basra, Iraq are cancer of breast, lymphoma, and cancer of ovary.
- The most frequent cancer types among children in Basra, Iraq are leukemia, cancer of brain/ CNS, and lymphoma.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
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The incidence of various cancers is increasing globally and is predicted to rise from 14.1 million new cases in 2012 to 20 million new 
cases in 2025.1 The proportion of cancer-related 
deaths increased from 14% in 2005 to 16% in 2015.2,3 
With around 8.8 million global deaths in 2015, cancer 
has been recognised as the second leading cause of 
death after cardiovascular disease worldwide.3 Various 
studies predicted around 18.1 million new cancer 
cases and 9.6 million cancer deaths would be recorded 
globally in 2018.4 It was further estimated that in 2018, 
nearly 50% of all new cancer cases and over 50% of all 
cancer deaths would occur in Asia.4
Regional variations in cancer epidemiology have 
been well documented and are attributable to societal, 
economic and lifestyle changes across different 
regions.4 Although incidence, survival and mortality 
rates have been reported in many populations, very 
little is known about cancer incidence specifically 
in Iraq.6,7 Basra, located in the southern part of Iraq, 
has witnessed an increase in its cancer incidence 
and mortality rates since 2005.8 Therefore, this 
study aimed to determine the incidence rates and 
gender distribution of various cancers in the Basra 
Governorate of Iraq using epidemiological analysis.
Methods
This observational, cancer-registry-based study 
analysed all malignant cancer cases diagnosed from 
1 January to 31 December 2017 in Basra, Iraq. The 
Basra Cancer Registry (BCR) was initiated in 1992 
and is maintained by the Basra Cancer Control 
Centre (BCCC). The BCR compiles cancer-related 
epidemiological information from all major hospitals 
(both public and private) in Basra, including Basra 
Oncology and Haematology Centre, Basra Children’s 
Hospital and the Basra College of Medicine. The 
BCR also compiles data from early detection centres, 
forensic medicine departments and all private 
laboratories including histopathology or haematology. 
Data was collected through active monthly visits 
to the above-mentioned sites and a passive review from 
the BCR records of the BCCC because, according to a 
Basra Health Directorate decision, cancer notification 
has been mandatory since 2008. The collected data 
included demographic information (name, gender, age, 
address and nationality) and tumour details (diagnosis 
date, primary site and histology). Cases reported from 
governorates other than Basra were excluded from the 
study. Anonymised data of all cases from the Basra 
Governorate were computerised using the CanReg-3 
programme (International Association of Cancer 
Registries, Lyon, France). Using the programme’s 
modules, duplicate entries of the same cancer case 
were removed and verified cases were analysed.
The cancer incidence in populations of different 
age groups and of both genders was calculated. 
Patients’ ages at time of diagnosis were recorded and 
the average age and incidence rates of different types of 
cancer were calculated for adults. Adults were defined 
as patients aged ≥15 years and children were defined 
as patients aged <15 years. 
The institutional ethics committee of College of 
Medicine, University of Basra, Iraq granted approval 
for this study.
Results
A total of 2,579 cases of cancer were recorded, of which 
416 patients were excluded because they were not 
residents of Basra Governorate. The final total sample 
size was 2,163. Cancers were confirmed through 
histology/cytology (n = 1,910; 88.3%), haematology 
(n = 102, 4.7%), radiology (n = 102; 4.7%), clinically 
(n = 26; 1.2%) and by autopsy (n = 11; 0.5%). For the 
remaining 12 (0.6%) cases, the method of diagnosis 
was unknown. 
The vast majority of cancer cases (n = 2,020; 
93.4%) were recorded in adults while the remaining (n 
Application to Patient Care: 
- Epidemiological knowledge helps to understand the current burden of disease.
- Future studies about incidence of cancer can help to identify the trends of increasing/ decreasing incidences in each cancer types in each 
gender/age group.
- This information is also helpful for policymakers to devise strategies to combat cancer by formulating national programs. 
 
Figure 1: Incidence rate of cancer per 100,000 people 
across different age groups in Basra, Iraq in 2017.
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= 143; 6.6%) were in children. The mean age of patients 
was 52.4 ± 15.2 years for adults and 6.4 ± 4.23 years 
for children. In adults, the mean age at the time of 
diagnosis was higher in males (57.7 ± 16.7 years) than 
females (51.4 ± 19.6 years). The incidence rate was 
72/100,000 people [Figure 1]. The age-standardised 
rate was 129.82. The cancer incidence rate per 100,000 
people was highest among patients aged >70 years and 
42% of the cases diagnosed in 2017 were 50–69 years 
old [Table 1].
Breast cancer was the most common type of 
cancer among adults in Basra, constituting 27.67% of 
the total cases diagnosed in 2017 with an incidence 
rate of 31.01 per 100,000 people. The five most 
frequent cancers (breast cancer, lymphoma, lung 
and bronchus cancer, urinary bladder cancer and 
colorectal cancer) constituted 53.47% of all cancer 
cases in Basra [Table 2]. In children, leukaemia was 
the commonest type of cancer recorded (4.66/100,000 
children; 39.2%), followed by cancers of the brain/
central nervous system (2/100,000 children; 16.8%; 
CNS), lymphoma (1.16/100,000 children; 9.8%) and 
bone cancer (1/100,000 children; 8.4%) [Table 3].
Of the 2,020 cancer cases in adults, there was 
slight female preponderance with 1,191 (59%) cases 
in females versus 829 (41%) cases in males, yielding 
a male-to-female ratio of 1:1.43. In adult males, 
urinary bladder cancer was the most common type, 
representing 11.94% of cancers, followed by lung and 
bronchus cancer (10.86%), lymphoma (8.56%) and 
colorectal cancers (8.44%). In adult females, breast 
cancer was the most common representing 45.42% 
of cancers, followed by lymphoma (6.13%), ovarian 
cancer (5.12%) and uterine cancer (4.21%). The 
frequency of cancers affecting various organs varied 
between genders [Figure 2].
Discussion
Annual numbers of deaths worldwide due to cancer 
exceeds the total number of deaths attributed to 
tuberculosis, malaria and HIV/AIDS combined.9 
Approximately 75% of total cancer deaths occur in 
low- and middle-income countries (LMICs).10 Cancer 
incidence in these countries is increasing rapidly due 
to changing demographics and increased exposure to 
various risk factors.10 
The present study reports the epidemiology 
of various cancers in Basra, Iraq, during 2017. The 
cancer incidence rate in 2017 (72/100,000 people) 
increased by over 30% from 2005 (54.26/100,000 
people).8 More broadly, the Eastern Mediterranean 
region has witnessed a marked increase in cancer 
Table 2: Frequency of occurrence and incidence rates per 
100,000 people for the 10 most frequent types of cancer 
in the total adult population of the Basra, Iraq in 2017
Type of cancer n (%) Incidence rate per 
100,000 adults
Breast 559 (27.7) 31.0
Lymphoma 144 (7.1) 8.0
Lung and bronchus 132 (6.5) 7.3
Urinary bladder 127 (6.3) 7.0
Colorectal 118 (5.8) 6.5
Leukaemia 84 (4.2) 4.7
Unknown primary 76 (3.8) 4.2
Prostate 63 (3.1) 3.5
Ovary and stomach 61 (3.0) 3.4
Brain/CNS 59 (2.9) 3.3
Total (n = 2,020) 1,423 
(70.4)
79.0
CNS = central nervous system.
Table 1: Distribution of cancer incidence and incidence rate 
per population of 100,000 across different age groups in 
Basra, Iraq in 2017 (N = 2,163)
Age group 
in years
n (%) Population Incidence rate per 
100,000 people
>10 97 (4.5) 873,046 11.1
10–19 85 (3.9) 673,993 12.6
20–29 109 (5.0) 501,563 21.7
30–39 205 (9.5) 398,226 51.5
40–49 366 (16.9) 281,546 130.0
50–59 442 (20.4) 142,241 310.7
60–69 475 (22.0) 89,846 528.7




Table 3: Frequency of occurrence of the 10 most frequent 
types of cancer and incidence rate per 100,000 children 
below the age of 15 years in Basra, Iraq in 2017
Type of cancer n (%) Incidence rate per 
100,000 children
Leukaemia 56 (39.2) 4.7
Brain/CNS 24 (16.8) 2.0
Lymphoma 14 (9.8) 1.2
Bone 12 (8.4) 1.0
Soft tissue 9 (6.3) 0.7
Kidney 7 (4.9) 0.6
Neuroblastoma 7 (4.9) 0.6
Other BM disorders 4 (2.8) 0.3
Eye 3 (2.1) 0.2
Liver 2 (1.4) 0.2
Total (n = 143) 138 (96.5) 11.5
CNS = central nervous system; BM = bone marrow.
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incidence from 494,690 in 2005 to 722,646 in 2015, 
although the increment of increase varies depending 
on countries’ economic status.12 For example, the rate 
of increase was moderate in low-income countries 
such as Afghanistan (47.2%), Djibouti (49.4%), Somalia 
(67.6%) and Yemen (49.4%). A similar pattern was also 
recorded in middle-income countries such as Egypt 
(40.6%), Jordan (54.1%), Lebanon (78.2%), Morocco 
(45.3%), Pakistan (44.6%) and Sudan (44.7%). By 
contrast, the cancer incidence increased drastically in 
high-income countries such as Kuwait (79.6%), Oman 
(123.9%), Saudi Arabia (67.6%) and the United Arab 
Emirates (182.9%; UAE).12 
Gender distribution in cancer incidence is an 
important aspect of cancer epidemiology. In Western 
countries such as the USA, UK and Europe, cancer 
affects males more than females.13,14 In contrast, in 
Middle Eastern countries, cancer affects females more 
than males, as observed in the current study as well as 
previous studies that focused on different parts of Iraq, 
 
Figure 2: Frequency of occurrence of different types of cancer in adult males (A) and females (B) in Basra, Iraq, in 2017.
CNS = central nervous system.
Table 4: Frequency of occurrence and incidence rate per 100,000 adult males/females of the 10 most frequent types of 
cancer in adult males and females in Basra, Iraq in 2017
Type of cancer in 
adult males
n (%) Incidence rate 
per 100,000 adult 
males
Type of cancer in 
adult females
n (%) Incidence rate 
per 100,000 adult 
females
Urinary bladder 99 (11.9) 10.9 Breast 541 (45.4) 60.6
Lung and bronchus 90 (10.9) 10.0 Lymphoma 73 (6.1) 8.2
Lymphoma 71 (8.6) 7.8 Ovary 61 (5.1) 6.8
Colorectal 70 (8.4) 7.7 Uterus 50 (4.2) 5.6
Prostate 63 (7.6) 7.0 Colorectal 49 (4.1) 5.5
Leukaemia 41 (4.9) 4.5 Leukaemia 43 (3.6) 4.8
Stomach 37 (4.5) 4.1 Lung and bronchus 42 (3.5) 4.7
Kidney 36 (4.3) 4.0 Unknown primary 41 (3.4) 4.6
Unknown primary 35 (4.2) 3.8 Cervix 31 (2.6) 3.5
Brain and CNS 31 (3.7) 3.4 Brain and CNS, 
thyroid
29 (2.4) 3.3
Total (n = 829) 573 (69.1) 63.0 Total (n = 1,191) 960 (80.6) 107.6
CNS = central nervous system.
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and the Eastern Mediterranean region, including the 
UAE and Kuwait.6,15,16 
Breast cancer represents approximately 45% of all 
cancer types in LMICs.17 Reflecting this observation, 
the current study found that breast cancer was the 
commonest cancer in Basra in 2017. Similar findings 
have been reported from Europe and the USA where 
the most frequent cancers as of 2018 in females 
was breast cancer, followed by cancers affecting the 
colorectal region and the lungs and bronchus.18 The 
incidence rate of breast cancer in the current study 
was found to be 60.64/100,000 adult females, which 
is similar to findings reported in Egypt (49.6/100,000), 
Jordan (38.0/100,000) and Israel (36.7/100,000) but 
lower than rates reported in the Western world 
(97.2/100,000 females in the USA).17 In Arab countries, 
the incidence rate of breast cancer is increasing rapidly 
due to rapid industrialisation and both delayed and 
reduced fertility.19 Other contributing risk factors 
leading to the increasing incidence of breast cancer 
in Arab countries include obesity, family history, 
hormonal therapy, post-menopause status, lack of 
education and no history of breastfeeding.20 Breast 
cancer was also reported to have the highest incidence 
rate in females in Sulaymaniyah, Iraq, between 2006–
2014.21 Similar to findings of the current study, Al-
Janabi et al. reported high incidence rates of breast, 
thyroid and colorectal cancers in females of Karbala, 
Iraq.6
The current study found urinary bladder cancer 
to be the most frequent cancer among Iraqi males, 
affecting 11.94% of the males in the study with an 
incidence rate of 10.88/100,000 males. Across the 
world, urinary bladder cancer is the seventh most 
common type of cancer diagnosed in males.23 Various 
cities of Iraq have witnessed high rates of urinary 
bladder cancer, accounting for nearly 13–15% of total 
cases of cancer.24 The high incidence and mortality 
of bladder cancer in the Middle East has also been 
previously reported.25 The reason for the high 
incidence of bladder cancer in Iraq needs to be further 
explored.
In comparison to the current findings, the 
incidence rates of lung cancer, leukaemia and 
lymphoma reported in males in Sulaymaniyah, Iraq, 
between 2006–2014 were 7.12, 4.5 and 4.32 per 
100,000 people, respectively.21 Prostate cancer was 
the fifth most common cancer among males in the 
current study. In contrast, prostate cancer has been 
reported as the most frequent cancer amongst males 
in the USA and Europe according to the World Health 
Organization’s (WHO) 2018 GLOBOCAN data.26,27 
One possible explanation for the seemingly lower 
incidence of prostate cancer among Iraqi males is the 
overdiagnosis of prostate cancer in men in Europe and 
USA due to prostate specific antigen screening which 
is perhaps less observed in Iraq. Future studies are 
warranted to identify other factors contributing to this 
observed difference in epidemiology between males 
from Iraq and the Western world. 
In this study, the commonest childhood cancer 
was leukaemia followed by brain/CNS cancers and 
lymphomas (39.2%, 16.8% and 9.8%, respectively). 
In Basra between 2012–2016, the incidences of 
these three cancers were 35.4%, 11.9% and 17.8%, 
respectively.7 Even in Iran’s Golestan Province in 
2010, a similar pattern was reported.28 The three most 
frequent childhood cancers were leukaemia (41.7%), 
lymphoma (11.5%) and brain and CNS cancers 
(10.1%).28 
A major limitation of the current study is that, 
as this was a hospital-based registry, the calculated 
cancer incidence might not be as accurate as a 
population-based cancer registry. However, hospital-
based cancer registries have value as tools for policy 
formulations and region-specific data creation, 
especially in resource-poor regions.29 At present, the 
International Association of Cancer Registries-backed 
national cancer registry is involved in generating 
national-level cancer incidence rates in coordination 
with the WHO’s GLOBOCAN project.30 To the best 
of the authosrs’ knowledge, a population-based cancer 
registry does not exist which caters exclusively to the 
population of Basra. The data from this study can 
contribute to a more accurate estimation of cancer 
epidemiology in Iraq. The numbers obtained from the 
various sources were reported descriptively so do not 
statistically predict the future incidence of cancer in 
Basra. The heavy focus on the epidemiological aspects 
of cancer resulted in not collecting data pertaining 
to factors influencing cancer such as smoking habits, 
social and economic status, marital status and the 
presence of comorbidities.
Conclusion
In the current study, a hospital-based cancer registry 
was analysed for trends in cancer incidence in Basra, 
Iraq, in 2017. Breast cancer was the most frequent 
cancer type among adults and adult females, and 
urinary bladder cancer and leukaemia were the most 
frequent cancer types among adult males and children, 
respectively. This epidemiological study could be used 
as a tool to identify cancer risks and plan accordingly.
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